What Is Nanomedicine?

Nanomedicine is the application of nanotechnology concepts and nanoscale materials to medical prevention, diagnosis, and treatment. It is defined by its operating scale: the devices, carriers, and constructs it employs have at least one functional dimension in the 1 to 100 nanometer range, comparable to the size of proteins, nucleic acids, lipid membranes, and cell receptors. At this scale, materials interact with biological systems at the molecular level, enabling precisely targeted delivery of drugs, real-time imaging of cellular processes, and detection of disease biomarkers at concentrations below those accessible by conventional clinical assays.

The field integrates chemistry, materials science, biology, biomedical engineering, and clinical medicine. As reviewed in nanomedicine challenges and perspectives published in Angewandte Chemie, nanomedicine differs from conventional therapies in that it can be designed to make molecular decisions, killing or repairing specific cells based on biosensor feedback rather than applying a systemic treatment that affects healthy and diseased tissue alike.

Nanoparticles for Drug Delivery

Nanoparticles are the primary delivery vehicles in nanomedicine, designed to encapsulate, protect, and release therapeutic agents at a target site. Polymeric nanoparticles, liposomes, solid lipid nanoparticles, dendrimers, and inorganic nanoparticles (gold, iron oxide, silica) each provide different combinations of drug loading capacity, release kinetics, and surface chemistry. Surface functionalization with polyethylene glycol (PEG) reduces uptake by the mononuclear phagocyte system and extends circulation time; conjugating ligands such as antibodies, aptamers, or folate to the surface enables active targeting of receptors overexpressed on tumor cells. The nano-based drug delivery systems review published in the Journal of Nanobiotechnology documents how passive accumulation through the enhanced permeability and retention (EPR) effect and active targeting together improve the fraction of an administered dose that reaches the intended tissue. Clinically approved nanomedicines include liposomal doxorubicin, albumin-bound paclitaxel, and iron oxide nanoparticles approved as MRI contrast agents.

Nanobiotechnology and Diagnostics

Nanobiotechnology applies nanoscale tools and structures to the study of biological systems, providing the measurement and characterization methods that nanomedicine depends on for both research and clinical use. Quantum dot fluorescent probes enable multiplexed imaging of cellular targets at resolution and contrast levels that organic dyes cannot achieve. Gold nanoparticles conjugated to antibodies or nucleic acid probes serve as colorimetric or surface-enhanced Raman scattering (SERS) labels for detecting pathogens, cancer biomarkers, and genetic mutations. Nanowire field-effect transistors and nanopore sensors detect single molecules of DNA, RNA, or protein with sensitivities relevant to early-stage disease detection. These tools provide the biosensor feedback that nanomedicine research in Science Advances identifies as essential for next-step theranostic platforms that combine diagnosis and therapy in a single nanoparticle construct.

Cellular Biophysics

Cellular biophysics investigates the physical forces, mechanical properties, and thermodynamic constraints that govern cell behavior, and its integration with nanomedicine enables the design of nanoscale devices that can interact productively with living cells. The stiffness, membrane fluidity, and cytoskeletal tension of a cell influence how nanoparticles are internalized and trafficked, which pathways route them toward or away from the nucleus, and whether a drug payload is released in the correct intracellular compartment. Atomic force microscopy cantilevers operating at the nanoscale can probe the mechanical properties of individual cell membranes, quantify receptor-ligand binding forces, and map the surface topography of cells at sub-nanometer vertical resolution. Understanding these biophysical parameters allows engineers to design nanocarrier surfaces with mechanical stiffness, shape, and ligand spacing that maximize cellular uptake and endosomal escape for therapeutic gene and drug delivery.

Applications

Nanomedicine has applications in a wide range of fields, including:

• Oncology, where targeted nanoparticles deliver cytotoxic drugs to tumor tissue while sparing healthy organs
• Gene therapy, using lipid nanoparticles and viral-mimetic vectors to deliver mRNA, siRNA, or CRISPR-Cas9 components into cells
• Infectious disease, where nanoparticle-formulated vaccines and antiviral agents improve immunogenicity and bioavailability
• Medical imaging, using iron oxide, gold, and gadolinium nanoparticles as MRI and CT contrast agents
• Regenerative medicine, where nanoscale scaffolds and growth factor delivery systems guide tissue repair and organ engineering